July 2025 in “Pakistan Journal of Rehabilitation” Over half of physiotherapy students in Lahore experience hair loss, highlighting the need for better education and early treatment.
May 2026 in “Bioorganic Chemistry”
June 2025 in “Indian Dermatology Online Journal” Severe hair loss may worsen with skin condition, suggesting treating the skin might help.
February 2026 in “European Journal of Pharmacology” Teicoplanin may help treat hair loss by reducing androgen receptors and boosting hair cell growth.
44 citations
,
May 2023 in “MedComm” PROTAC technology shows promise for cancer treatment but needs more effective E3 ligase recruiters.
The conclusion cannot be provided because the document content is not available.
13 citations
,
April 2015 in “Journal of Dermatology” Finasteride effectively promotes hair growth and reduces hair loss in men with androgenetic alopecia.
1 citations
,
January 2018 in “Annals of Medical and Health Sciences Research” People with male pattern baldness are more likely to have metabolic syndrome.
January 2014 in “Jaypee Brothers Medical Publishers (P) Ltd. eBooks” Androgenetic alopecia is the most common cause of hair loss, affecting both men and women, with varying patterns and prevalence among different races.
December 2023 in “European Journal of Medicinal Chemistry” Natural products might be safe, effective, and affordable treatments for hair loss.
Higher levels of certain proteins in hair loss areas may help understand and treat hair loss.
4 citations
,
December 2021 in “Dermatologic Therapy” Mesotherapy for hair loss can cause temporary forehead swelling.
March 2023 in “Benha Journal of Applied Sciences” Medications for male pattern hair loss are safe and work well.
April 2026 in “Zenodo (CERN European Organization for Nuclear Research)” The model improves understanding of androgen interactions by focusing on signal intensity and system capacity.
2 citations
,
January 2019 in “Annals of Dermatology” Certain gene variations in EGF and EGFR may increase the risk of alopecia areata in Koreans.
Men with androgenetic alopecia may have higher triglycerides, suggesting a link to lipid metabolism.
Cepharanthine could be a strong antiviral against COVID-19.
18 citations
,
August 2012 in “Chinese journal of integrative medicine/Chinese Journal of Integrative Medicine” Both treatments for alopecia areata are equally effective and safe.
13 citations
,
March 2017 in “Genomics” Genomic approach finds new possible treatments for hair loss.
May 2023 in “International Journal of Trichology” Tofacitinib may be an effective and safe treatment for hair loss in teenagers with alopecia areata.
7 citations
,
April 2021 in “Journal of Pharmacy and Pharmaceutical Sciences” Cetirizine 1% helps hair growth in men with no major side effects, but minoxidil 5% works better.
30 citations
,
September 2017 in “Clinics in Dermatology” Men with common hair loss may have a higher risk of heart disease and diabetes, and should be checked for these conditions.
4 citations
,
December 2021 in “Journal of Cosmetic Dermatology” Severe hair loss is linked to worse COVID-19 outcomes, especially in younger men.
January 2021 in “Menoufia Medical Journal” People with early-onset androgenetic alopecia may have a higher risk of heart disease due to abnormal blood lipid levels.
May 2025 in “The Journal of Rheumatology” Early diagnosis and treatment are crucial for CAPS, and Eculizumab can be effective.
5-ARI therapy may help prevent prostate cancer progression.
November 2015 in “Springer eBooks” Hair loss treated with minoxidil, finasteride, laser/light, hair transplant, and scalp prostheses; more research needed for skin of color.
January 2022 in “International Journal of Health Science” Topical products, especially specific shampoos, are effective in treating androgenetic alopecia by delivering active ingredients to hair follicles and improving hair quality.
1 citations
,
September 2020 in “Pediatric Dermatology” Two teenage boys lost hair after taking a drug for growth, which was not a known side effect for kids.
Metformin can cause rare severe skin reactions.